Cardiovascular and Metabolic Effects of Açaí, an Amazon Plant

Journal of Cardiovascular Pharmacology

Volumn 68, Issue 1, 2016, Pages 19-26

  De Moura, Roberto S ^a   Resende, Ângela Castro ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

antioxidant; a a ; hypertension; metabolic syndrome; polyphenols; vasodilation

Indexed keywords

ANTIOXIDANT; LIPID; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; POLYPHENOL; REACTIVE OXYGEN METABOLITE; VASODILATOR AGENT; CARDIOVASCULAR AGENT; PLANT EXTRACT;

ACAI; ANTIOXIDANT ACTIVITY; BERRY; CARDIOVASCULAR FUNCTION; CHEMICAL COMPOSITION; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DYSLIPIDEMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIPID METABOLISM; MEDICINAL PLANT; NONHUMAN; PHYTOCHEMISTRY; PLANT SEED; PRIORITY JOURNAL; REVIEW; SKIN; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; EUTERPE; FRUIT; ISOLATION AND PURIFICATION; METABOLIC DISEASES; METABOLISM; PATHOPHYSIOLOGY; PHYTOTHERAPY;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; EUTERPE; FRUIT; HUMANS; METABOLIC DISEASES; PHYTOCHEMICALS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84949591495     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000347     Document Type: Review

References (83)

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311-335.
2. de Souza MO, Souza E Silva L, de Brito Magalhães CL, et al. The hypocholesterolemic activity of acai (Euterpe oleracea Mart.) is mediated by the enhanced expression of the ATP-binding cassette, subfamily G transporters 5 and 8 and low-density lipoprotein receptor genes in the rat. Nutr Res. 2012;32:976-984.
3. Yamaguchi KK, Pereira LFR, Lamarão CV, et al. Amazon acai: chemistry and biological activities: a review. Food Chem. 2015;179:137-151.
4. Plotkin MJ, Balick MJ. Medicinal uses of South American palms. J Ethnopharmacol. 1984;10:157-179.
5. Schauss AG, Wu X, Prior RL, et al. Phytochemical and nutrient composition of the freeze-dried Amazonian palm berry, Euterpe oleraceae mart. (acai). J Agric Food Chem. 2006;54:8598-8603.
6. Cavararo R. Produção da extração vegetal e da silvicultura. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística. 2013;28:1-69.
7. Del Pozo-Insfran D, Brenes CH, Talcott ST, et al. Phytochemical composition and pigment stability of acai (Euterpe oleracea Mart.). J Agric Food Chem. 2004;52:1539-1545.
8. Lichtenthäler R, Rodrigues RB, Maia JG, et al. Total oxidant scavenging capacities of Euterpe oleracea Mart. (Acai) fruits. Int J Food Sci Nutr. 2005;56:53-64.
9. Matheus ME, de Oliveira Fernandes SB, Silveira CS, et al. Inhibitory effects of Euterpe oleracea Mart. on nitric oxide production and iNOS expression. J Ethnopharmacol. 2006;107:291-296.
10. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16:144-158.
11. Rocha AP, Carvalho LC, Sousa MA, et al. Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (Acai) extracts in mesenteric vascular bed of the rat. Vascul Pharmacol. 2007;46:97-104.
12. Rodrigues RB, Lichtenthäler R, Zimmermann BF, et al. Total oxidant scavenging capacity of Euterpe oleracea Mart. (acai) seeds and identification of their polyphenolic compounds. J Agric Food Chem. 2006;54: 4162-4167.
13. Moura RS, Ferreira TS, Lopes AA, et al. Effects of Euterpe oleracea Mart. (Acai) extract in acute lung inflammation induced by cigarette smoke in the mouse. Phytomedicine. 2012;19:262-269.
14. Romanowski A, Murray JR, Huston MJ. Effects of hydrogen peroxide on normal and hypertensive rats. Pharm Acta Helv. 1960;35:354-357.
15. Montezano AC, Touyz RM. Molecular mechanisms of hypertension- reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol. 2012;28:288-295.
16. Kizhakekuttu TJ, Widlansky ME. Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther. 2010;28:e20-e32.
17. Leo CH, Woodman OL. Flavonols in the prevention of diabetes-induced vascular dysfunction. Cardiovasc Pharmacol. 2015;65:532-544.
18. Santos GM, Maia GA, Sousa PH, et al. Correlation between antioxidant activity and bioactive compounds of acai (Euterpe oleracea Mart) commercial pulps. Arch Latinoam Nutr. 2008;58:187-192.
19. Paz M, Gúllon P, Barroso MF, et al. Brazilian fruit pulps as functional foods and additives: evaluation of bioactive compounds. Food Chem. 2015;172:462-468.
20. Mertens-Talcott SU, Rios J, Jilma-Stohlawetz P, et al. Pharmacokineticsof anthocyanins and antioxidant effects after the consumptionof anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem. 2008;56:7796-7802.
21. da Costa CA, de Oliveira PR, de Bem GF, et al. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2012;385: 1199-1209.
22. Oliveira PR, da Costa CA, de Bem GF, et al. Effects of an extract obtained from fruits of Euterpe oleracea Mart. in the components of metabolic syndrome induced in C57BL/6J mice fed a high-fat diet. J Cardiovasc Pharmacol. 2010;56:619-626.
23. de Bem GF, da Costa CA, de Oliveira PR, et al. Protective effect of Euterpe oleracea Mart (acai) extract on programmed changes in the adult rat offspring caused by maternal protein restriction during pregnancy. J Pharm Pharmacol. 2014;66:1328-1338.
24. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-376.
25. Vanhoutte PM. Endothelium and control of vascular function. State of the art lecture. Hypertension. 1989;13:658-667.
26. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291:H985-H1002.
27. Félétou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol. 2011;164: 894-912.
28. Vanhoutte PM, Miller VM. Alpha 2-adrenoceptors and endotheliumderived relaxing factor. Am J Med. 1989;87:1S-5S.
29. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
30. Förstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol. 2011;164:213-223.
31. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 2010;459:793-806.
32. Li Q, Youn JY, Cai H. Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens. 2015;33: 1128-1136.
33. Noble MA, Munro AW, Rivers SI. Potentiometric analysis of the flavin cofactors of neuronal nitric oxide synthase. Biochemistry. 1999;38: 16413-16418.
34. Li H, Poulos TI. Structure-function studies on nitric oxide synthases. J Inorg Biochem. 2005;99:293-305.
35. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric0oxide synthases. J Biol Chem. 2001;276:14533-14536.
36. Kuzkaya N, Weissmann N, Harrison DG, et al. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and tiol: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278: 22545-22554.
37. Werner ER, Gorren AC, Heller R, et al. Tetrahydrobiopterin and nitric oxide: mechanismic and pharmacological aspects. Exp Biol Med. 2003; 228:1291-1302.
38. Chen ZP, Mitchelhill KI, Michell BJ, et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999;443: 285-289.
39. Morrow VA, Foufelle F, Connell JM, et al. Direct activation of AMPactivated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biolchem. 2003;278:31629-31639.
40. Duarte J, Pérez-Palencia R, Vargas F, et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol. 2001;133:117-124.
41. Fitzpatrick DF, Fleming RC, Bing B, et al. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem. 2000;48:6384-6390.
42. Schini-Kerth VB, Etienne-Selloum N, Chataigneau T, et al. Vascular protection by natural product-derived polyphenols: in vitro and in vivo evidence. Planta Med. 2011;77:1161-1167.
43. Rees DD, Palmer RM, Hodson HF, et al. A specific inhibitor of nitric oxide formation from l-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
44. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
45. Page IH. Pathogenesis of arterial hypertension. J Am Med Assoc. 1949; 140:451-458.
46. Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6:599-608.
47. Soares De Moura R, Costa Viana FS, Souza MA, et al. Antihypertensive, vasodilator and antioxidant effects of a vinifera grape skin extract. J Pharm Pharmacol. 2002;54:1515-1520.
48. Sarr M, Chataigneau M, Martins S, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res. 2006;71:794-802.
49. Rocha AP, Resende AC, Souza MA, et al. Antihypertensive effects and antioxidant action of a hydro-alcoholic extract obtained from fruits of Euterpe oleracea Mart. (acai). J Pharmacoltoxicol. 2008;3:435-448.
50. Cordeiro VS, Carvalho LR, de Bem GF. Euterpe oleracea Mart. extract prevents vascular remodeling and endothelial dysfunction in spontaneously hypertensive rats. Int J Appl Res Nat Prod. 2015;8:6-16.
51. Vidal MJ, Romero JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol. 1988;149:401-425.
52. Wagner C, Pfeifer A, Ruth P, et al. Role of cGMP-kinase II in the control of renin secretion and renin expression. J Clin Invest. 1998;102: 1576-1582.
53. Yang Y, Macdonald GJ, Duggan KA. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat. Clin Sci (Lond). 2001;100:319-326.
54. Giani JF, Janjulia T, Kamat N, et al. Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition. J Am Soc Nephrol. 2014;25:2752-2763.
55. Fraser SA, Choy SW, Pastor-Soler NM, et al. AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1. Am J Physiol Renal Physiol. 2013;305:F679-F690.
56. Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003; 278:45021-45026.
57. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
58. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
59. Gale AM, Kaur R, Baker WL. Hemodynamic and electrocardiographic effects of acai berry in healthy volunteers: a randomized controlled trial. Int J Cardiol. 2014;174:421-423.
60. Udani JK, Singh BB, Singh VJ, et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutr J. 2011;10:45-51.
61. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
62. Zapata-Sudo G, da Silva JS, Pereira SL, et al. Oral treatment with Euterpe oleracea Mart. (acai) extract improves cardiac dysfunction and exercise intolerance in rats subjected to myocardial infarction. BMC Complement Altern Med. 2014;14:227-233.
63. Unis A. Acai berry extract attenuates glycerol-induced acute renal failure in rats. Ren Fail. 2015;37:310-317.
64. El Morsy EM, Ahmed MA, Ahmed AA. Attenuation of renal ischemia \reperfusion injury by acai extract preconditioning in a rat model. Life Sci. 2015;123:35-42.
65. Barker DJ. Fetal origens of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31:1235-1239.
66. Frasch MG, Müller T, Wicher C, et al. Fetal body weight and the development of the control of the cardiovascular system in fetal sheep. J Physiol. 2007;579:893-907.
67. Sathishkumar K, Elkins R, Yallampalli U, et al. Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J Vasc Res. 2009;45:229-239.
68. Mesquita FF, Gontijo JA, Boer PA. Maternal undernutrition and the offspring kidney: from fetal to adult life. Braz J Med Biol Res. 2010;43:1010-1018.
69. Rodford JL, Torrens C, Siow RC, et al. Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease. J Physiol. 2008;586:4709-4720.
70. Pires KM, Aguila MB, Mandarim-de-Lacerda CA. Early renal structure alteration in rat offspring from dams fed low protein diet. Life Sci. 2006; 79:2128-2134.
71. Sperling LS, Mechanick JI, Neeland IJ, et al. The cardio metabolic health alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol. 2015;66:1050-1067.
72. Mozumder A, Liguory G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999-2006. Diabetes Care. 2011;34:216-219.
73. de Souza MO, Silva M, Silva ME, et al. Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition. 2010;26:804-810.
74. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, et al. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endotheliumdependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 1986;58:552-564.
75. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans. 2002;30:1064-1070.
76. Ruderman NB, Cacicedo JM, Itani S, et al. Malonyl-CoA and AMPactivated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans. 2003;31(pt 1):202-206.
77. Hardie DG, Corton J, Ching YP, et al. Regulation of lipid metabolism by the AMP-activated protein kinase. Biochem Soc Trans. 1997;25: 1229-1231.
78. Osborne TF. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem. 2000;275:32379-32382.
79. van der Wulp MY, Verkade HJ, Groen AK. Regulation of cholesterol homeostasis. Mol Cell Endocrinol. 2013;368:1-16.
80. Heyman L, Axling U, Blanco N, et al. Evaluation of beneficial metabolic effects of berries in high-fat fed C57BL/6J mice. J Nutr Metab. 2014; 2014:403041.
81. Triggle CR, Ding H. Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis. 2014;5:245-268.
82. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2011;8:228-236.
83. Zou MH, Kirkpatrick SS, Davis BJ. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem. 2004;279: 43940-43951.